Promising Role of Oral Cavity Mesenchymal Stem Cell-Derived Extracellular Vesicles in Neurodegenerative Diseases

Mol Neurobiol. 2022 Oct;59(10):6125-6140. doi: 10.1007/s12035-022-02951-y. Epub 2022 Jul 22.

Abstract

Mesenchymal stem cells (MSCs) and mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have been regarded as the beneficial and available tools to treat various hereditary, multifactorial, acute, and chronic diseases. Mesenchymal stem cells can be extracted from numerous sources for clinical purposes while oral cavity-derived mesenchymal stem cells seem to be more effective in neuroregeneration than other sources due to their similar embryonic origins to neuronal tissues. In various studies and different neurodegenerative diseases (NDs), oral cavity mesenchymal stem cells have been applied to prove their promising capacities in disease improvement. Moreover, oral cavity mesenchymal stem cells' secretion is regarded as a novel and practical approach to neuroregeneration; hence, extracellular vesicles (EVs), especially exosomes, may provide promising results to improve CNS defects. This review article focuses on how oral cavity-derived stem cells and their extracellular vesicles can improve neurodegenerative conditions and tries to show which molecules are involved in the recovery process.

Keywords: Exosomes; Extracellular vesicles; Neurodegenerative disease; Oral cavity; Regenerative medicine; Stem cell therapy.

Publication types

  • Review

MeSH terms

  • Exosomes*
  • Extracellular Vesicles*
  • Humans
  • Mesenchymal Stem Cells*
  • Mouth
  • Neurodegenerative Diseases* / therapy